Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial.

CMR of microvascular obstruction and hemorrhage in myocardial infarction. J Cardiovasc Magn Reson (2012) 1.33

Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney. J Nephropathol (2013) 0.96

Erythropoietin action in stress response, tissue maintenance and metabolism. Int J Mol Sci (2014) 0.91

Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era. World J Cardiol (2014) 0.87

Erythropoietin receptor (EpoR) agonism is used to treat a wide range of disease. Mol Med (2013) 0.82

Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats. J Control Release (2013) 0.82

The mitochondria-targeted antioxidants and remote kidney preconditioning ameliorate brain damage through kidney-to-brain cross-talk. PLoS One (2012) 0.79

Baseline Hemoglobin Levels Associated with One-Year Mortality in ST-Segment Elevation Myocardial Infarction Patients. Acta Cardiol Sin (2016) 0.77

rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial. BMC Res Notes (2015) 0.77

Erythropoietin and organ protection: lessons from negative clinical trials. Crit Care (2014) 0.75

Erythropoietin studies should not be abandoned. Am Heart J (2012) 0.75

Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med (2015) 5.90

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol (2008) 5.77

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.21

Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med (2005) 4.80

CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res (2005) 3.03

Rho kinases in cardiovascular physiology and pathophysiology. Circ Res (2006) 2.97

Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med (2012) 2.88

Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry. Circulation (2014) 2.76

Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J (2010) 2.63

Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry. Circulation (2011) 2.47

Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest (2007) 2.34

Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation (2008) 2.33

Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials. Arch Intern Med (2006) 2.28

Feasibility of right ventricular longitudinal systolic function evaluation with transthoracic echocardiographic indices derived from tricuspid annular motion: a preliminary study in acute respiratory distress syndrome. Echocardiography (2012) 2.18

Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann Intern Med (2006) 2.17

Pivotal role of bedside Doppler echocardiography in the assessment of patients with acute heart failure and mitral regurgitation. Cardiology (2009) 2.03

Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J (2004) 1.98

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1. Thromb Haemost (2010) 1.96

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheter Cardiovasc Interv (2003) 1.95

Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur Heart J (2011) 1.93

Accuracy of multislice computed tomography in the preoperative assessment of coronary disease in patients with aortic valve stenosis. J Am Coll Cardiol (2006) 1.85

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J (2014) 1.81

Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol (2008) 1.80

Midterm benefits of left univentricular pacing in patients with congestive heart failure. Circulation (2004) 1.77

apTreeshape: statistical analysis of phylogenetic tree shape. Bioinformatics (2005) 1.74

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroIntervention (2013) 1.72

Midterm prognosis of patients with suspected coronary artery disease and normal multislice computed tomographic findings: a prospective management outcome study. Arch Intern Med (2007) 1.71

Increased radial force improves stent deployment in tricuspid but not in bicuspid stenotic native aortic valves. Ann Thorac Surg (2010) 1.66

High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J (2005) 1.64

Spatially explicit Bayesian clustering models in population genetics. Mol Ecol Resour (2010) 1.57

Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry. Circ Cardiovasc Interv (2014) 1.55

Functional decline in elderly patients presenting with acute coronary syndromes: impact on midterm outcome. Arch Cardiovasc Dis (2009) 1.54

A novel type II secretion system in Pseudomonas aeruginosa. Mol Microbiol (2002) 1.54

Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J (2008) 1.54

Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J (2005) 1.53

The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients. Am Heart J (2006) 1.48

Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit. Ann Thorac Surg (2008) 1.45

Towards a structural comprehension of bacterial type VI secretion systems: characterization of the TssJ-TssM complex of an Escherichia coli pathovar. PLoS Pathog (2011) 1.44

Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest. Am Heart J (2008) 1.40

Relationship between beta-blocker and angiotensin-converting enzyme inhibitor dose and clinical outcome following acute myocardial infarction. Circ J (2015) 1.39

Traumatic leaflet injury during the use of percutaneous valves: a comparative study of balloon- and self-expandable valved stents. Eur J Cardiothorac Surg (2012) 1.38

Percutaneous aortic valve implantation: what does oversizing mean? J Thorac Cardiovasc Surg (2009) 1.37

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J (2004) 1.34

Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet (2002) 1.32

Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol (2005) 1.31

Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circ Res (2008) 1.31

Severity of acute pulmonary embolism: evaluation of a new spiral CT angiographic score in correlation with echocardiographic data. Eur Radiol (2002) 1.29

Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol (2005) 1.24

Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J (2010) 1.23

Routine breath-hold gradient echo MRI-derived right ventricular mass, volumes and function: accuracy, reproducibility and coherence study. Int J Cardiovasc Imaging (2004) 1.19

Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J (2010) 1.17

Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2005) 1.15

Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. Chest (2011) 1.13

RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol (2011) 1.12

Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart (2012) 1.11

Fractal geometry of arterial coronary bifurcations: a quantitative coronary angiography and intravascular ultrasound analysis. EuroIntervention (2008) 1.08

Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry. EuroIntervention (2014) 1.06

TssK is a trimeric cytoplasmic protein interacting with components of both phage-like and membrane anchoring complexes of the type VI secretion system. J Biol Chem (2013) 1.05

Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction. Circulation (2003) 1.05

Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling. Basic Res Cardiol (2010) 1.05

Joint injections in patients on antiplatelet or anticoagulant therapy: risk minimization. Joint Bone Spine (2002) 1.05

Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovasc Res (2006) 1.04

Multipotent progenitor cells in gingival connective tissue. Tissue Eng Part A (2010) 1.02

Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy. J Crit Care (2009) 1.00

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol (2003) 1.00

Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter. EuroIntervention (2008) 0.98

Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace (2004) 0.97

Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound. Circulation (2004) 0.97

The XcpV/GspI pseudopilin has a central role in the assembly of a quaternary complex within the T2SS pseudopilus. J Biol Chem (2009) 0.97

The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. Am Heart J (2007) 0.97

Cardiac tamponade in medical patients: a 10-year follow-up survey. Cardiology (2008) 0.96

Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction. Heart Vessels (2010) 0.96

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials. Circ Cardiovasc Qual Outcomes (2011) 0.95

Collagen and elastin cross-linking: a mechanism of constrictive remodeling after arterial injury. Am J Physiol Heart Circ Physiol (2005) 0.95

Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. Am J Cardiol (2008) 0.94

Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J (2012) 0.94

Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosis. Arterioscler Thromb Vasc Biol (2005) 0.93

The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure. Eur J Heart Fail (2005) 0.93

Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning. PLoS One (2013) 0.93

Quantitative assessment of regurgitant flow with total digital three-dimensional reconstruction of color Doppler flow in the convergent region: in vitro validation. J Am Soc Echocardiogr (2002) 0.93

Adenovirus-mediated gene transfer of superoxide dismutase and catalase decreases restenosis after balloon angioplasty. J Vasc Res (2005) 0.93

Management of cardiac arrest caused by coronary artery spasm: epinephrine/adrenaline versus nitrates. Heart Lung (2008) 0.92

Structure of the Pseudomonas aeruginosa XcpT pseudopilin, a major component of the type II secretion system. J Struct Biol (2009) 0.92

Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice. Atherosclerosis (2005) 0.92

Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Arch Cardiovasc Dis (2013) 0.91

Patient selection for TAVI in 2014: is it justified to treat low- or intermediate-risk patients? The cardiologist's view. EuroIntervention (2014) 0.91

Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning. J Mol Cell Cardiol (2013) 0.90

Fractional flow reserve: concepts, applications and use in France in 2010. Arch Cardiovasc Dis (2010) 0.90

Hypertrophic cardiomyopathy associated with left ventricular apical aneurysm. Arch Cardiovasc Dis (2009) 0.90

The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction. Basic Res Cardiol (2014) 0.89